trial · primary record
Lenbelintide
Obesity or Overweight
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1500 |
| Primary completion | 2028-08-09 |
| Primary endpoint | Percent change in body weight from baseline at 68 weeks of treatment. |
| Registry ID | NCT07784270 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:19.470Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07784270
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.